Inequitable Conduct Behind Regeneron Patent, Judge Finds
Regeneron Pharmaceuticals Inc. hid information from the U.S. Patent and Trademark Office for a mice genes patent and used "troubling litigation tactics" in a New York infringement suit, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article